Stellar Secure Business Platforms Revenue and Competitors

NZ

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Stellar Secure Business Platforms's estimated annual revenue is currently $1.7M per year.(i)
  • Stellar Secure Business Platforms's estimated revenue per employee is $87,000

Employee Data

  • Stellar Secure Business Platforms has 19 Employees.(i)

Stellar Secure Business Platforms's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Product and Sales ManagerReveal Email/Phone
4
Senior Fullstack DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$524.8M25314%$3.3MN/A
#2
$3.8M33N/AN/AN/A
#3
$78.1M43122%N/AN/A
#4
$0.4M6N/AN/AN/A
#5
$4.6M40N/AN/AN/A
#6
$19.6M135N/AN/AN/A
#7
$0.7M9N/AN/AN/A
#8
$7.6M582%N/AN/A
#9
$0.3M4N/AN/AN/A
#10
$16M110N/AN/AN/A
#11
$0.2M3N/AN/AN/A
#12
$0.2M3N/AN/AN/A
#13
$1M12N/AN/AN/A
#14
$2866.5M15750N/AN/AN/A
#15
$1.7M19N/AN/AN/A
#16
$2.7M27N/AN/AN/A
#17
$0.6M8N/AN/AN/A
#18
$16.8M11612%N/AN/A
#19
$2.3M23N/AN/AN/A
#20
$2.3M23N/AN/AN/A
Add Company

What Is Stellar Secure Business Platforms?

keywords:N/A

N/A

Total Funding

19

Number of Employees

$1.7M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Stellar Secure Business Platforms News

2022-04-20 - Sanofi's Dupixent still 'at the beginning' of the journey: exec

Sanofi's Dupixent puts on another stellar show, and it's still 'at the beginning' of the ... Eli Lilly is feeling pretty secure these days.

2022-04-19 - Integrating Asset Management Into Your SOC With Open XDR ...

With this integration, CYRISMA brings a rich suite of asset management capabilities to the Stellar Cyber Open XDR platform. It: Integrates...

2022-04-06 - Where to Buy Stellar Lumens 2022 Guide - Invest in XLM

The best platform place to buy Stellar Lumens is eToro. ... account due to their nonconforming status as startups/small businesses owners.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M190%N/A
#2
$1.2M190%N/A
#3
$1.1M19-14%N/A
#4
$3.7M19-5%N/A
#5
$1.7M19N/AN/A